✦ LIBER ✦

Differences in Inhaled Fluticasone Bioavailability Between Holding Chambers in Children with Asthma

✍ Scribed by Dr. Judy Liang; Dr. Michael J. Asmus; Dr. Günther Hochhaus; Dr. Sarah Chesrown; Dr. Leslie Hendeles

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Inhalation therapy in asthma: Nebulizer

✍ Johannes H. Wildhaber; Nigel D. Dore; Joyce M. Wilson; Sunalene G. Devadason; Pe 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 40 KB

Adherence to Oral Montelukast and Inhale

✍ Dr. James Sherman; Dr. Parul Patel; Dr. Alan Hutson; Dr. Sarah Chesrown; Dr. Les 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 27 KB

Fluticasone propionate (FP) CFC delivere

✍ Crim, C.C.; Nathan, R.A.; Baker, J.W.; Bensch, G.W.; Faris, M.A.; Herje, N.E.; S 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 144 KB

In Vitro Performance Characteristics of

✍ Dr. Michael J. Asmus; Dr. Judy Liang; Dr. Intira Coowanitwong; Dr. Günther Hochh 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 282 KB

Reformulated fluticasone propionate hydo

✍ Robert W. Wilmott 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 46 KB

Fluticasone propionate administered via

✍ CRIM, C 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 26 KB